-

Pulse8 Returns to RISE Nashville 2020

CHICAGO--(BUSINESS WIRE)--Pulse8, the cutting-edge healthcare analytics and technology company, is excited to return as a Platinum Sponsor of RISE Nashville 2020 and kick off this event with a valuable Pre-Conference Workshop on What Health Plans and Providers Should Be Seeing at the Crossroads of Better Data and Advanced Analytics.

In its 14th year, the annual RISE Nashville Summit continues to host thought leaders, key stakeholders, and influencers of all levels in the Medicare Advantage, Medicaid, ACA Commercial, ACO markets and maintains its place as the must-attend opportunity to learn about the latest technologies, best practices, and regulatory trends. During Pulse8’s Pre-Conference workshop taking place on March 15th, attendees will hear from Pulse8’s industry experts, as well as notable health plan and provider partners, on topics such as:

  • Value-based Care: Synergizing Advanced Analytics, Technologies, and Interoperability for more successful Risk Adjustment and Quality Outcomes;
  • Reducing Plan and Provider Burden for Better Engagement and Outcomes in a rapidly shifting Healthcare Landscape; and
  • Integrating Risk, Quality, and Pharmacy Opportunities at the Point of Care to improve Clinical and Financial Outcomes

“We are thrilled to sponsor RISE Nashville 2020 and to host our 4th workshop addressing hot topics in the industry today. We look forward to the robust discussion about what your health system and health plan should be achieving from its data and analytics, and how we are the best at making that happen,” says John Criswell, CEO of Pulse8. “Our purpose continues to be eliminating wasteful and unnecessary interventions that deliver no value and this workshop delivers upon our commitment to achieve this objective on how analytics and predictive techniques can improve quality of care.”

Visit Pulse8’s booth to speak with subject matter experts and industry leaders from the team. To schedule a meeting or demo, please call Scott Filiault at 732.570.9095 or email him at Scott.Filiault@pulse8.com.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

About Pulse8:

Pulse8 is a Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Our advanced analytic methodologies and flexible business intelligence tools offer real-time visibility into member behavior and provider performance. Pulse8’s Illumin8 Active Intelligence™ platform offers a suite of uniquely pragmatic solutions that are powered by our patent-pending Dynamic Intervention Planning to deliver the most cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality. For more company information or to schedule a demo, please Info@Pulse8.com.

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Files 2023 and 2024 Form 10-K

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Report on Form 10-K for the years ended December 31, 2023 and 2024 (the “2023 and 2024 Form 10-K”) with the Securities and Exchange Commission (“SEC”). “In our previous shareholder update, I framed a critical must-do to get current and stay current on our SEC filings. Today marks a major milestone in tha...

Veradigm to Release Business Update May 26th and Host Investor Call May 27th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on Tuesday, May 26, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update on Wednesday, May 27th, at 8:00 a.m. Eastern Time. Update Call Details Veradigm plans to issue a press release afte...

Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the availability of the Veradigm Health Network Architecture™ to early adopter customers. Veradigm Health Network Architecture provides independent practices a single real-time view of their clinical, financial, and operational performance and helps close a capability gap that has historically separated independent practices from large health...
Back to Newsroom